However, the expression of PD-L1 is also associated with a more favorable clinical course in CRC and SCCHN [67], whereas in a recent meta-analysis, progression-free survival improved in SCCHN patients with PD-L1 expression [67]. The gene discussed is CD274; the disease is colorectal carcinoma.